Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

Blood - ResearchHub

ResearchGate

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal

Blood

0006-4971 · American Society of Hematology

14 verified public works

Browse all journals →

Liso-cel delivers: is the debate over for 3L FL?

2026 · 0 citations

Menin inhibitors unleash JUND-mediated resistance mechanisms

2026 · 0 citations

Measuring factor VIII after gene therapy: which assay?

2026 · 0 citations

Better together in NPM1 -mutated AML

2026 · 0 citations

Systems reboot: a niche-based approach to AML

2026 · 0 citations

Lu J, Xue S, Wang Y, et al. Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML. Blood . 2025;145(22):2645-2655.

2026 · 0 citations

Wagner DL, Elsallab M, Maus MV. Promises and potential pitfalls of in vivo CAR gene therapy. Blood . 2026;148(5):535-544.

2026 · 0 citations

How I treat thrombotic microangiopathy in the setting of triggers

2026 · 0 citations

Durable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL

2026 · 0 citations

FGF18 mediates fibroblast-leukemia cross talk to promote acute myeloid leukemia progression

2026 · 0 citations

A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL

2026 · 0 citations

One-stage assay factor VIII activity reflects AAV-derived factor VIII–enhanced thrombin activation and predicts phenotype

2026 · 0 citations

Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells, contributing to tumorigenesis and therapy resistance

2026 · 0 citations

Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1 -mutated acute myeloid leukemia

2026 · 0 citations

Page 1 of 1